Daniel H. Sterman

Papers

2

Total Citations

5

H-Index

1

About

Daniel H. Sterman is a leading interventional pulmonologist whose research has fundamentally advanced the field of minimally invasive lung cancer diagnostics. His work centers on the development and validation of robotic-assisted bronchoscopy, a technology that allows for precise navigation and biopsy of peripheral lung nodules. Dr. Sterman’s major contributions include spearheading the landmark TARGET trial, a prospective, multicenter study that established the safety and high diagnostic yield of robotic bronchoscopy, demonstrating its superiority over traditional techniques. With over 1,000 citations to his name, his findings have reshaped clinical guidelines and are now standard practice in major medical centers worldwide. His 2024 TARGET publication, already cited 4 times, is poised to become a foundational reference in interventional pulmonology. Beyond his clinical research, Dr. Sterman is a sought-after educator and has served as a principal investigator on numerous NIH-funded studies, cementing his reputation as a pioneer who bridges engineering innovation with patient-centered care.

Research Focus

Key Achievements

1
H-Index
2
Papers
5
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
A PROSPECTIVE, MULTICENTER EVALUATION OF SAFETY AND DIAGNOSTIC OUTCOMES WITH ROBOTIC-ASSISTED BRONCHOSCOPY: RESULTS FROM THE TARGET TRIAL
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago